Aguilar RF

Language: Spanish
References: 19
Page: 22-26
PDF size: 96.20 Kb.

ABSTRACT

The restless legs syndrome (RLS) is characterized by an unpleasant sensation in the legs which causes an imperative need to move the legs and is therefore considered to be a disorder of movement. When it appears before going to sleep, it may interference with falling asleep and lead to a sleep-deficit. RLS is a clinical condition with a satisfactory treatment, and improvement of the associated sleep disorder. The etiology is unknown, is divided in primary and secondary, sometimes it is familial. The syndrome is increasingly often misdiagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy. Polysomnography is not necessary, unless one suspects an associated disorder of periodic leg movements. Treatment is by dopaminergic, opiate, benzodiazepine, anticonvulsant drugs such as Gabapentin or alpha-adrenergic clonidine.

REFERENCES

1. Chokroverty S, Jankovic J. Restless legs syndrome. A disease in search of identity. Neurology 1999;52:907-910.

2. Goodman JD, Brodie C, Ayida GA. Restless legs syndrome in pregnancy. Br Med J 1988;297:1101-1102.

3. Allen RP et al. Restless legs syndrome prevalence and impact: REST population bases study. Arch Internal Medicine 2005;23(3):200-203.

4. Walters AS, Hickey K, Maltzman J et al. A questionnaire study of 138 patients with restless legs syndrome: the night Walker’s Survey Neurology 1996;46:92-95.

5. Hening W et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST primary care study. Sleep Med 2004;5(3):237-246.

6. Montagna P. Motor disorders of sleep. In Culebras A, ed. Sleep disorders and Neurological Disease. New York: Marcel Dekker 2000:252.

7. Hening W, Alien R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999;22:970-999.

8. Brodeur C, Montplaisir J, Godbout R. Treatment of restless legs syndrome and periodic movements during sep with L-dopa A double-blind, controlled study. Neurology 1988;38:1845-1848.

9. Walters AS, and the International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-642.

10. Collado-Seidel V, Kazenwadel J, Wetter TC. A controlled study of additional sr- L dopa in L-dopa responsive restless legs syndrome with late-night symptoms patients diagnosed with new standard criteria. Mov Disord 1977;12:61-65.

11. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesparence P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 Neurology 1999;52:285-290.

12. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: Development of scoring method Neurology 1992;42:1371-4.S.

13. Hening W et al. The treatment of restless legs syndrome and periodic limb moment disorder. An Academy of Sleep Medicine Review. Sleep 1999;22(7):970-999.

14. Montagna P, Sassoli de Bianchi L, Zucconi M. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984;69:428-430.

15. Edinger JD, Fins Al, Sullivan RJ. Comparison of cognitive-beheavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep1996;19;442-444.

16. Yasuda T, Nishimura A, Katsuki Y, Tsuji Y. Restless legs syndrome treated successfully by kidney transplantation a case report. Clin Transpl 1986;12:138.

17. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin) Sleep 1996;19:224-226.

18. Earley CJ, Alien RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996;19:801-810.

19. Molnar M et al. Restless legs syndrome in patients after renal transplantation. Am J Kidney Dis 2005;45(2);388-396.